We are live on ! Find out more
ENZ

Enzo Biochem, Inc.
ENZ

Delisted

ENZ was delisted on the 17th of April, 2025.

Back to rankings

0 hedge funds and large institutions have $0 invested in Enzo Biochem, Inc. in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 6 → 0 (-6)

100% less capital invested

Capital invested by funds: $254K → $0 (-$254K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Holders
–
Holders Change
-6
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RC
RBF Capital
California
-$102K
2
Squarepoint
Squarepoint
New York
-$95.4K
3
XT
XTX Topco
Cayman Islands
-$30.4K
4
KCM
Kempner Capital Management
Texas
-$17K
5
GSC
Ground Swell Capital
South Carolina
-$9.33K
Name Holding Trade Value Shares
Change 		Change in
Stake
RC
1
RBF Capital
California
– -$102K -150,000 Closed
Squarepoint
2
Squarepoint
New York
– -$95.4K -140,637 Closed
XT
3
XTX Topco
Cayman Islands
– -$30.4K -44,880 Closed
KCM
4
Kempner Capital Management
Texas
– -$17K -25,475 Closed
GSC
5
Ground Swell Capital
South Carolina
– -$9.33K -13,761 Closed

ENZ Hedge Fund Activity: Q3 2025 in Review

0 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q3 2025, worth a combined $0 — down 100% from $254K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ENZ and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RBF Capital, exiting entirely with an estimated $102K sold.

  • 0 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q3 2025, down from 6 in Q2 2025.
  • Funds reported $0 of Enzo Biochem, Inc. stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Enzo Biochem, Inc. positions in Q3 2025 and 6 closed out, a net change of -6 holders.
  • The largest Enzo Biochem, Inc. seller in Q3 2025 was RBF Capital, an estimated $102K sold.

Based on aggregated 13F filings for Q3 2025.